Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorZhuan Zhang

About this trial

Venous pressure is often overlooked as an important hemodynamic parameter. Elevated venous pressure and blood stasis in organ tissues can lead to interstitial edema. Intraoperative venous blood stasis can rapidly increase interstitial pressures within organ tissues, especially in organs encapsulated by tissue envelopes, such as the kidney, thereby rapidly reducing effective circulating blood flow to the organ. Systemic venous blood stasis, which tends to occur in patients with right heart failure or pulmonary hypertension, as well as in patients with fluid overload, can lead to intraoperative stasis in multiple organs and tissues, mediating the development of multisystem complications, including acute kidney injury. Therefore, timely, effective, and accurate intraoperative assessment of systemic venous blood stasis is particularly important.

When right heart failure and/or volume overload occurs in the body, changes in right atrial pressure are transmitted to the venous system of organs throughout the body, with dilatation of the inferior vena cava (IVC), obstruction of blood return from the hepatic, portal, and renal veins, and abnormal venous flow signals and altered ultrasound Doppler flow patterns.

The primary objective of this prospective cohort study is to explore if intraoperative systemic venous congestion during cardiac surgery is associated with postoperative CSA-AKI. In doing so, we seek to identify a promising physiological marker that can provide cues for the prediction of CSA-AKI. This study will also investigate the relationship between intraoperative systemic venous congestion and postoperative complications, and explore the relationship between each separate venous congestion and AKI after cardiac surgery.

Eligibility criteria

Qualifiers

Patients scheduled to undergo elective cardiac surgery;

≥ 18 years.

Disqualifiers

Contraindications for TEE;

Emergency cardiac surgery;

Major vascular surgery;

Redo cardiac surgery;

Trial design

Treatments tested in this trial

  • collection of demographic characteristics and comorbidities
  • surgery-related parameters and kidney function assessments
  • collection of biological (laboratory) parameters
  • collection of hemodynamic parameters
  • collection of echocardiographic parameters and venous ultrasound assessments

Treatment groups

114 Participants
are divided into 1 treatment group

Sponsors and collaborators

Zhuan Zhang

Lead sponsor

Yangzhou University

Sponsor institution